Pseudotumor Cerebri Secondary to Use of All-Trans Retinoic Acid for Treatment of Acute Promyelocytic Leukemia

Update Item Information
Identifier 20200308_nanos_posters_036
Title Pseudotumor Cerebri Secondary to Use of All-Trans Retinoic Acid for Treatment of Acute Promyelocytic Leukemia
Creator Philip Kim; Amanda Henderson
Affiliation (PK) (AH) The Johns Hopkins Wilmer Eye Institute, Baltimore, MD
Subject Pseudotumor cerebri, High Intracranial Pressure/Headache
Description Multiple randomized trials have demonstrated that all-trans retinoic acid (ATRA) improves the outcome of patients with acute promyelocytic leukemia (APL). Secondary pseudotumor cerebri has been estimated to occur in 1.7% of overall APL patients treated with ATRA and is more common in children. We present a case of an adult with pseudotumor cerebri secondary to ATRA therapy.
Date 2020-03
Language eng
Format application/pdf
Type Text
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2020: Poster Session I: Clinical Highlights
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6xh50v5
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 1539267
Reference URL https://collections.lib.utah.edu/ark:/87278/s6xh50v5
Back to Search Results